SEC Form 4 · accession 0001104659-18-045777
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Pomerantz
Director
Period of report
Jul 17, 2018
Accepted (ET)
Jul 18, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $23.00 | Jul 17, 2018 | A | 25,000 | A | — | Jul 16, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option shall vest in equal quarterly installments during the twelve quarters following the grant date.